companydata.dkcompanydata.dk

AGC Biologics A/S: Financial statements 2014

CVR: 25950941

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 311,091,000 and a net result of DKK 3,181,000 compared with DKK -128,000 the year before. The profit margin was 1%. Equity in the 2014 report amounted to DKK 139,522,000. The solvency ratio was 40.3%. The company had 199 employees in the financial year.

Revenue
DKK 311,091,000
Gross Profit
DKK 45,843,000
Profit/Loss
DKK 3,181,000
Equity
DKK 139,522,000
Total Assets
DKK 346,594,000
Employees
199

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014311.1M45.8M3.2M139.5M199
2013-37.2M-128K136.3M185

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Jesper Bramming joins the board of AGC Biologics A/SJun 27, 2014

As of June 27, 2014, Jesper Bramming has joined the board of directors of AGC Biologics A/S.

Mads Aage Laustsen leaves the board of AGC Biologics A/SJun 27, 2014

As of June 27, 2014, Mads Aage Laustsen has left the board of directors of AGC Biologics A/S.

AGC Biologics A/S: The 2013 annual report is outJun 4, 2014

AGC Biologics A/S has published its annual report for 2013. Gross profit came to DKK 37,248,000, and the net result was DKK -128,000.

Mads Aage Laustsen joins the board of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, Mads Aage Laustsen has joined the board of directors of AGC Biologics A/S.

Patricio Ezequiel Massera joins the board of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, Patricio Ezequiel Massera has joined the board of directors of AGC Biologics A/S.

David Kauffmann leaves the board of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, David Kauffmann has left the board of directors of AGC Biologics A/S.

Claès Johan Robert Glassell leaves the board of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, Claès Johan Robert Glassell has left the board of directors of AGC Biologics A/S.

Mads Aage Laustsen steps down as director of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, Mads Aage Laustsen has stepped down as director of AGC Biologics A/S.

Claès Johan Robert Glassell steps down as director of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, Claès Johan Robert Glassell has stepped down as director of AGC Biologics A/S.

Gustavo Fabio Mahler steps down as director of AGC Biologics A/SJan 14, 2014

As of January 14, 2014, Gustavo Fabio Mahler has stepped down as director of AGC Biologics A/S.

About AGC Biologics A/S

AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.

Source: annual report 2025, Danish Business Authority